Workboat Indexes
Immunitybio Inc (NQ: IBRX )
4.165
-0.025
(-0.60%)
Streaming Delayed Price
Updated: 11:14 AM EDT, Aug 28, 2024
Add to My Watchlist
All News about Immunitybio Inc
![](/images/schema-image-default.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/premkt_movers_545.png)
![](https://mms.businesswire.com/media/20220131005962/en/760385/5/ImmunityBio.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/aapharma_3152.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/medicine-1309148_1920_401.jpg)
![](https://mms.businesswire.com/media/20220118006235/en/760385/5/ImmunityBio.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/biotech3_2.jpg)
![](https://mms.businesswire.com/media/20220112005430/en/760385/5/ImmunityBio.jpg)
![](https://mms.businesswire.com/media/20220104005428/en/760385/5/ImmunityBio.jpg)
ImmunityBio Awarded Seminal Patent on Natural Killer Cells
January 04, 2022
From ImmunityBio, Inc.
Via Business Wire
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/yesterdays_movers_363.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/aapharma_3007.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/yesterdays_movers_359.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/mid-day_movers_image_87.jpg)
![](https://mms.businesswire.com/media/20211220005286/en/760385/5/ImmunityBio.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/yesterdays_movers_352.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/yesterdays_movers_340.png)
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2021/movers_image_5242.jpeg?width=720)
![](https://mms.businesswire.com/media/20211118005433/en/760385/5/ImmunityBio.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/aapharma_2420.png)
![](https://mms.businesswire.com/media/20211104005486/en/760385/5/ImmunityBio.jpg)
ImmunityBio to Present at the Jefferies London Healthcare Conference
November 04, 2021
From ImmunityBio, Inc.
Via Business Wire
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/aapharma_2210.png)
![](https://mms.businesswire.com/media/20211019005500/en/760385/5/ImmunityBio.jpg)
![](https://mms.businesswire.com/media/20211013005442/en/760385/5/ImmunityBio.jpg)
![](https://mms.businesswire.com/media/20211004005349/en/760385/5/ImmunityBio.jpg)
![](https://mms.businesswire.com/media/20210913005298/en/760385/5/ImmunityBio.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/covid-19_vaccine_image_by_wilfried_pohnke_from_pixabay__27.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/medicine-1309148_1920_371.jpg)
![](https://mms.businesswire.com/media/20210907005330/en/760385/5/ImmunityBio.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.